Aureobasidium.org

patent 2023

Biological healing accelerator – Japan (Patent No. 5715659)

Iwai A., Uchiyama H. · Japanese Patent Office
Research Archive
TL;DR — Key Findings
  • Japanese patent for AP β-glucan as biological healing accelerator.
  • Healing acceleration likely mediated through macrophage activation in tissue repair.
  • Wound healing patents expand AP-glucan applications into regenerative medicine.

Abstract

Biological healing accelerator – Japan (Patent No. 5715659)

Patent Details

Country of RegistrationJapan

Patent No.No. 5715659Registration DateMar. 20, 2015Remarks※ Promoting the healing of “thermal burns

Currently, Aureobasidium (black yeast) culture medium (hereafter referred to as “Aureo culture medium”) has been approved in Japan, Europe (UK, France, Germany), China, Hong Kong, Taiwan, and Thailand to reduce the side effects of anticancer drugs and to promote healing of erythema caused by burn wounds.

Summary

Summary

Patent Overview

Japanese Patent No. 5715659 (License No. 5331482 extension) covers Aureobasidium pullulans-derived β-glucan as a biological healing accelerator. This patent protects formulations and methods that use N-163 strain β-glucan to enhance the body's natural healing processes, supporting tissue repair and immune activation following injury or illness.

Significance

This Japanese patent is part of the core intellectual property portfolio protecting Aureobasidium pullulans β-glucan applications in biological healing and immune support, held by the Sonoda-Iwai research group.

Citation

Iwai A., Uchiyama H.. Biological healing accelerator – Japan (Patent No. 5715659). Japanese Patent Office. 2023.

Study Details
Study Type
patent
Published
2023
Journal
Japanese Patent Office
Authors
Iwai A., Uchiyama H.
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.